Federal contract award
HDTRA118C0031
C2-0482 STTR PHASE II
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE THREAT REDUCTION AGENCY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AD95 — OTHER DEFENSE - OPERATIONAL SYSTEMS DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Mar 16, 2018 |
| Current end date | Sep 15, 2020 |
| Potential end date | Sep 15, 2020 |
| Latest award activity | Jul 17, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 17, 2025 | P00007 | $0 | INFECTIOUS DISEASE DIAGNOSTICS AND DIFFERENTIATION OF VIRAL VS. BACTERIAL INFECTIONS FOR POINT OF CARE APPLICATIONS |
| Jul 17, 2025 | P00008 | $0 | INFECTIOUS DISEASE DIAGNOSTICS AND DIFFERENTIATION OF VIRAL VS. BACTERIAL INFECTIONS FOR POINT OF CARE APPLICATIONS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.